CROs can look forward to “steady but tentative growth” in the coming years, but the biggest gainers will be the largest companies in the business, with the…

Two major owners of INC Research have announced that they are to sell off 4.5 million shares as they look to lower their financial interest in the CRO.

Evotec has posted a 37% sales jump in the first half of 2016 with its income bumped up to €75.7 million ($84.1 million) as it reaps the benefits of its collabs…

Medpace has raised $161 million in its initial public offering, the top end of the CRO’s desired range, despite persistent headwinds for other sectors…

CRO giant INC Research has announced that its chief exec of three years, Jamie Macdonald, will be stepping down this fall as the company promotes current…

Irish CRO Icon made a strong showing in the second quarter as revenue and bookings jumped for the company.

Amsterdam-based contract drug developer Patheon has raised an eye-watering $625 million by offering 29.8 million shares at $21 a pop.

New York’s digital services provider for biopharma Medidata has posted what it is hailing as “record” numbers for the second quarter as it saw sales jump.

After a strong 6 months that has seen the best growth spurt in its history, Lonza is raising its guidance for the rest of the year.

Financials